Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.51 |
| ▸ | MDM4 | O15151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4300738 | 0.93 | KMT2A (0.58) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL20504185 | 0.93 | KMT2A (0.58) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL29650664 | 0.93 | KMT2A (0.58) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL38664780 | 0.91 | TLR2 (0.54) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL17826082 | 0.91 | KMT2A (0.56) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL13658468 | 0.91 | KMT2A (0.56) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL29400679 | 0.91 | KMT2A (0.56) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL12928621 | 0.91 | KMT2A (0.56) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL23421235 | 0.90 | TLR2 (0.49) | KMT2ACASP3PTPN1TLR2MDM4 | |
| SCHEMBL13996828 | 0.90 | TLR2 (0.49) | KMT2ACASP3TLR2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612124-A1 | AZOTOMYCIN PRODRUGS WITH PREFERENTIAL TUMOR DELIVERY | The Johns Hopkins University (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097320-A1 | AZOTOMYCIN PRODRUGS WITH PREFERENTIAL TUMOR DELIVERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-10 | — | — | WO | disclosed |